首页> 外文期刊>Journal of Crohn’s & colitis >Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment
【24h】

Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment

机译:抗TNF抗体血清浓度,炎症性肠病患者缓解治疗治疗患者的抗体效果和生活质量

获取原文
获取原文并翻译 | 示例
           

摘要

Background and aims: High serum concentrations of infliximab [IFX] and adalimumab [ADA] may be associated with adverse effects in patients with inflammatory bowel disease [IBD]. We aimed to investigate whether high anti-tumour necrosis factor [TNF] trough levels [TLs] were associated with toxicity and impaired quality of life [QoL].
机译:背景和目的:高血清血清浓度的英夫利昔单抗[IFX]和AdaLimualAb [ADA]可能与炎症性肠病患者的不利影响[IBD]。 我们的目的是探讨高抗肿瘤坏死因子[TNF]槽水平[TLS]与毒性和生活质量受损相关[QOL]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号